PrimeRFP SCOUT · Federal Contract Recompete Brief

MD NET

Contract75N91019F00139

MD NET is a federal award for Department of Health and Human Services (HHS) held by LEIDOS BIOMEDICAL RESEARCH, INC.. Estimated value $163.5M ($84.4M obligated). Current period of performance ends Sep 29, 2028. Place of performance: FREDERICK, MD. Related solicitation N02CO7240681.

$163.5M
Estimated Value
$84.4M
Obligated
Sep 29, 2028
PoP End / Expires
More in SCOUT — score this to your firm →See related expiring contracts →
AnalysisPublic

LEIDOS BIOMEDICAL RESEARCH, INC. holds $2.3B across 187 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75N91019D00024. Recompete timing centers on the Sep 29, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract factsFederal
Contract number75N91019F00139
AgencyDepartment of Health and Human Services (HHS)
IncumbentLEIDOS BIOMEDICAL RESEARCH, INC.
UEIHV8BH9BPG8Y9
NAICS541715
PSCAN12
Parent IDIQ / IDV75N91019D00024
Place of performanceFREDERICK, MD
Related solicitationN02CO7240681
PoP end (current)Sep 29, 2028
Obligated$84.4M
Recompete timingPublic
Expiring in 795 days

Current PoP ends Sep 29, 2028 (795 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Mar 29, 2027.

Track recompete timing in SCOUT →
Incumbent footprintPublic record

LEIDOS BIOMEDICAL RESEARCH, INC.$2.3B obligated across 187 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Open full company profile
Related awardsSame parent · incumbent
75N91021F00013
ENABLING NCI CLINICAL & RESEARCH DATA SHARING
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$81.1M
Aug 31, 2026
75N91020F00026
DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$56.5M
May 25, 2027
75N91020F00009
ON BEHALF OF NIAID-DCR, FACILITATE THE CONDUCT OF TWO, RANDOMIZED TRIALS AS DETAILED BELOW…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$89.6M
Jul 31, 2028
75N91020F00025
DCR IS REQUESTING THE SERVICES OF LEIDOS BIOMEDICAL RESEARCH, INC. TO INITIATE MANAGEMENT,…
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$97.5M
Sep 24, 2028
75N91020F00039
NIAID COVID-19 ACTIV3
Department of Health and Human Services (HHS) · LEIDOS BIOMEDICAL RESEARCH, INC.
$281.6M
Sep 29, 2029

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

More in SCOUT
Score this to your firm →

Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open LEIDOS BIOMEDICAL RESEARCH, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75N91019D00024-75N91019F00139